In-Human Implantation of a Novel Biologic Valved Conduit for Aortic Root Replacement.
Publication/Presentation Date
1-1-2022
Abstract
Aortic root replacement is a complex procedure. Recently, the KONECT RESILIA aortic valved conduit (Edwards Lifesciences, Irvine, CA), the first prefabricated biologic valved conduit available in the United States, was approved for use. Here, we report a series of 3 patients representing implantation of the novel Konect AVC. The conduit was implanted in both supraannular and intraannular positions, and the unique design of the sewing ring offers several advantages. The Konect AVC streamlines the process of root replacement and may represent an improvement in terms of ease of implantation and durability.
Volume
113
Issue
1
First Page
21
Last Page
21
ISSN
1552-6259
Published In/Presented At
DeRoo, S. C., Desai, N., Grimm, J. C., Cannon, B., & Bavaria, J. E. (2022). In-Human Implantation of a Novel Biologic Valved Conduit for Aortic Root Replacement. The Annals of thoracic surgery, 113(1), e21–e24. https://doi.org/10.1016/j.athoracsur.2021.03.087
Disciplines
Medicine and Health Sciences
PubMedID
33839132
Department(s)
Department of Surgery
Document Type
Article